U.S. markets closed

Cirrus Logic (CRUS) Q3 Earnings Surpass Estimates, Rise Y/Y

Zacks Equity Research

Cirrus Logic CRUS delivered third-quarter fiscal 2020 non-GAAP earnings per share of $1.41, which topped the Zacks Consensus Estimate of $1.12 as well as the year-ago figure of 91 cents.

Total revenues of $374.7 million also surpassed the Zacks Consensus Estimate of $346 million and improved 16% year over year as well. Higher-than-expected volumes of boosted amplifiers, haptic drivers and smart codecs shipping in smartphones drove revenues.

However, on a sequential basis, revenues declined 4% due to reduction in sales to certain Android customers, ahead of product launches in the first half 2020.

Quarterly Details

Segment wise, portable audio product revenues (92% of total revenues) came in at $344.87 million, up 19.5% year over year. However, non-portable audio and other products (8%) decreased 16.4% to $29.8 million.

Cirrus Logic’s largest customer, apparently Apple, accounted for 83% of its sales for the reported quarter.

Non-GAAP gross profit of $197.8 million increased 21% on a year-over-year basis. Non-GAAP gross margin expanded 240 basis points (bps) to 52.8%, driven by a favorable product mix. Supply chain efficiencies and cost reductions on certain products were also an upside

Cirrus Logic’s non-GAAP operating expenses inched up 2.8% to $103.2 million. Non-GAAP operating income of $94.6 million too surged 50.1%. Moreover, non-GAAP operating margin expanded 590 bps from the year-ago quarter to 25.3%.

Cirrus Logic, Inc. Price, Consensus and EPS Surprise

Cirrus Logic, Inc. Price, Consensus and EPS Surprise

Cirrus Logic, Inc. price-consensus-eps-surprise-chart | Cirrus Logic, Inc. Quote

Balance Sheet and Cash Flow

The company exited the fiscal third quarter with cash and cash equivalents of $342.3 million compared with $221.9 million at the end of the earlier reported quarter.

Accounts receivables were $175.9 million compared with $207.96 million in the last reported quarter. Notably, the company did not have any long-term debt during the quarter under review.

Cash flow from operations was $128.7 million in the quarter. As of Dec 28, 2019, the company has $170 million remaining under its share repurchase authorization.


The company expects fourth-quarter fiscal 2020 revenues between $250 million and $290 million, indicating a decline of 28% sequentially but an improvement of 13% year over year at the midpoint.

The guidance provided suggests strong demand for certain components shipping in smartphones, offset by normal seasonal trends.

Zacks Rank and Other Stocks to Consider

Currently, Cirrus Logic has a Zacks Rank #2 (Buy). A few other top-ranked stocks in the broader technology sector are Perficient PRFT, Synopsys, Inc. SNPS and ManTech International Corporation MANT, each flaunting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth rate for Perficient, Synopsys and ManTech is currently pegged at 11.75%, 12.76% and 8%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ManTech International Corporation (MANT) : Free Stock Analysis Report
Perficient, Inc. (PRFT) : Free Stock Analysis Report
Synopsys, Inc. (SNPS) : Free Stock Analysis Report
Cirrus Logic, Inc. (CRUS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research